Litemed

Litemed manufactures wearable light therapy devices for pain management relief, utilizing red and near-infrared light wavelengths to target musculoskeletal discomfort and joint stiffness. The technology is designed for application on various body areas to support tissue recovery and local circulation, functioning as a non-invasive, drug-free tool for managing chronic or acute physical pain through consistent daily use. Founded in 2022 and headquartered in Hyderabad, India, Litemed has raised approximately $4.6M in Seed funding from investors including Ideaspring Capital, Verlinvest, V3 Ventures, BIRAC, and 3i Partners. The company's wearable form factor enables convenient at-home photobiomodulation therapy, addressing the growing demand for non-pharmacological pain management alternatives in markets where opioid prescription concerns and chronic pain prevalence are driving interest in drug-free therapeutic devices.